Increased expression of the multidrug transporter P-glycoprotein in limbic brain regions after amygdala-kindled seizures in rats

Epilepsy Research

Volumn 58, Issue 1, 2004, Pages 67-79

  Volk, Holger A ^a   Potschka, Heidrun ^a   Löscher, Wolfgang ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

ABCB1; Antiepileptic drugs; Epilepsy; Multidrug resistance gene; Pharmacoresistance

Indexed keywords

ANTIBODY; ANTICONVULSIVE AGENT; CHROMOGENIC SUBSTRATE; DIAMINOBENZIDINE; DIAZEPAM; GLYCOPROTEIN P; GLYCOPROTEIN P ANTIBODY; KAINIC ACID; MULTIDRUG RESISTANCE PROTEIN; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CAPILLARY; BRAIN CORTEX; CONTROLLED STUDY; DENTATE GYRUS; ELECTRODE; ENDOTHELIUM CELL; EPILEPSY; FEMALE; HIPPOCAMPUS; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; KINDLING; LIMBIC CORTEX; MEASUREMENT; MULTIDRUG RESISTANCE; NONHUMAN; OPTICAL DENSITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRIFORM CORTEX; RAT; SEIZURE;

AMYGDALA; ANIMALS; CELL COUNT; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; EPILEPSY, TEMPORAL LOBE; EXCITATORY AMINO ACID TRANSPORTER 2; FEMALE; FUNCTIONAL LATERALITY; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; KINDLING, NEUROLOGIC; P-GLYCOPROTEIN; RATS; RATS, WISTAR;

EID: 1842608240     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2003.12.009     Document Type: Article

References (30)

1. de Boer A.G., van der Sandt I.C., Gaillard P.J. The role of drug transporters at the blood-brain barrier. Annu. Rev. Pharmacol. Toxicol. 43:2003;629-656.
2. Dobrogowska D.H., Vorbrodt A.W. Quantitative immunocytochemical study of blood-brain barrier glucose transporter (GLUT-1) in four regions of mouse brain. J. Histochem. Cytochem. 47:1999;1021-1030.
3. Dombrowski S.M., Desai S.Y., Marroni M., Cucullo L., Goodrich K., Bingaman W., Mayberg M.R., Bengez L., Janigro D. Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy. Epilepsia. 42:2001;1501-1506.
4. Farrell C.L., Pardridge W.M. Blood-brain barrier glucose transporter is asymmetrically distributed on brain capillary endothelial luminal and abluminal membranes: an electron microscopic immunogold study. Proc. Natl. Acad. Sci. USA. 88:1991;5779-5783.
5. Kim H., Barroso M., Samanta R., Greenberger L., Sztul E. Experimentally induced changes in the endocytic traffic of P-glycoprotein alter drug resistance of cancer cells. Am. J. Physiol. 273:1997;C687-C702.
6. Lee G., Dallas S., Hong M., Bendayan R. Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations. Pharmacol. Rev. 53:2001;569-596.
7. Löscher W. Animal models of intractable epilepsy. Prog. Neurobiol. 53:1997;239-258.
8. Löscher W. Current status and future directions in the pharmacotherapy of epilepsy. Trends Pharmacol. Sci. 23:2002;113-118.
9. Löscher W., Ebert U. Basic mechanisms of seizure propagation: targets for rational drug design and rational polypharmacy. Epilepsy Res. 11(Suppl.):1996;17-44.
10. Löscher W., Potschka H. Role of multidrug transporters in pharmacoresistance to antiepileptic drugs. J. Pharmacol. Exp. Ther. 301:2002;7-14.
11. Paxinos, G., Watson, C., 1998. The rat brain in stereotaxic coordinates, fourth ed. Academic Press, Sydney.
12. Potschka H., Löscher W. A comparison of extracellular levels of phenytoin in amygdala and hippocampus of kindled and non-kindled rats. Neuroreport. 13:2002;167-171.
13. Racine R.J. Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroencephgr. Clin. Neurophysiol. 32:1972;281-294.
14. Rajagopal A., Simon S.M. Subcellular localization and activity of multidrug resistance proteins. Mol. Biol. Cell. 14:2003;3389-3399.
15. Regesta G., Tanganelli P. Clinical aspects and biological bases of drug-resistant epilepsies. Epilepsy Res. 34:1999;109-122.
16. Rieux C., Carney R., Lupi D., Dkhissi-Benyahya O., Jansen K., Chounlamountri N., Foster R.G., Cooper H.M. Analysis of immunohistochemical label of Fos protein in the suprachiasmatic nucleus: comparison of different methods of quantification. J. Biol. Rhythms. 17:2002;121-136.
17. Rizzi M., Caccia S., Guiso G., Richichi C., Gorter J.A., Aronica E., Aliprandi M., Bagnati R., Fanelli R., D'Incalci M., Samanin R., Vezzani A. Limbic seizures induce P-glycoprotein in rodent brain: functional implications for pharmacoresistance. J. Neurosci. 22:2002;5833-5839.
18. Rundfeldt C., Hönack D., Löscher W. Phenytoin potently increases the threshold for focal seizures in amygdala-kindled rats. Neuropharmacology. 29:1990;845-851.
19. Schinkel A.H. P-glycoprotein, a gatekeeper in the blood-brain barrier. Adv. Drug Deliv. Rev. 36:1999;179-194.
20. Seegers U., Potschka H., Löscher W. Expression of the multidrug transporter P-glycoprotein in brain capillary endothelial cells and brain parenchyma of amygdala-kindled rats. Epilepsia. 43:2002a;675-684.
21. Seegers U., Potschka H., Löscher W. Transient increase of P-glycoprotein expression in endothelium and parenchyma of limbic brain regions in the kainate model of temporal lobe epilepsy. Epilepsy Res. 51:2002b;257-268.
22. Sisodiya S.M., Heffernan J., Squier M.V. Over-expression of P-glycoprotein in malformations of cortical development. Neuroreport. 10:1999;3437-3441.
23. Sisodiya S.M., Lin W.-R., Harding B.N., Squier M.V., Keir G., Thom M. Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy. Brain. 125:2002;22-31.
24. Sisodiya S.M., Thom M. Widespread upregulation of drug-resistance proteins in fatal human status epilepticus. Epilepsia. 44:2003;261-264.
25. Tishler D.M., Weinberg K.T., Hinton D.R., Barbaro N., Annett G.M., Raffel C. MDR1 gene expression in brain of patients with medically intractable epilepsy. Epilepsia. 36:1995;1-6.
26. Wahnschaffe U., Löscher W. Lack of changes in seizure susceptibility during the estrous cycle in kindled rats. Epilepsy Res. 13:1992;199-204.
27. Willemse F., Nap M., de Kok L.B., Eggink H.F. Image analysis in immunohistochemistry. Factors with a possible influence on the performance of VIDAS version 2.0, a commercially available true color image analysis system. Anal. Quant. Cytol. Histol. 15:1993;136-143.
28. Willemse F., Nap M., Henzen-Logmans S.C., Eggink H.F. Quantification of area percentage of immunohistochemical staining by true color image analysis with application of fixed thresholds. Anal. Quant. Cytol. Histol. 16:1994;357-364.
29. Wolf H.K., Buslei R., Schmidt-Kastner R., Schmidt-Kastner P.K., Pietsch T., Wiestler O.D., Bluhmke I. NeuN: a useful neuronal marker for diagnostic histopathology. J. Histochem. Cytochem. 44:1996;1167-1171.
30. Zhang L., Ong W.Y., Lee T. Induction of P-glycoprotein expression in astrocytes following intracerebroventricular kainate injections. Exp. Brain Res. 126:1999;509-516.